+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ampio Pharmaceuticals Inc - logo

Ampio Pharmaceuticals is a biopharmaceutical company that focuses on developing therapies for the treatment of prevalent inflammatory conditions in the United States. Ampio has received over 180 patents throughout the world, with hundreds more pending. The company's leading product candidates are Ampion and Optina. Amption is a intra-articular injection being studied for the treatment of osteoarthritis of the knee. Optina is an oral agent being studied for the treatment of diabetic macular edema. Ampio is headquartered in Englewood, Colorado.

Diabetic Retinopathy Treatment - Global Strategic Business Report - Product Thumbnail Image

Diabetic Retinopathy Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 273 Pages
  • Global
From
From
From
From
From
Psoriasis Treatment Market Report and Forecast 2024-2032 - Product Thumbnail Image

Psoriasis Treatment Market Report and Forecast 2024-2032

  • Report
  • July 2024
  • 200 Pages
  • Global
From
From
Neuroblastoma - Pipeline Insight, 2024 - Product Thumbnail Image

Neuroblastoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Osteoarthritis - Pipeline Insight, 2024 - Product Thumbnail Image

Osteoarthritis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
Wet Macular Degeneration - Pipeline Insight, 2024 - Product Thumbnail Image

Wet Macular Degeneration - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Osteoarthritis Global Market Report 2024 - Product Thumbnail Image

Osteoarthritis Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Knee osteoarthritis - Pipeline Insight, 2024 - Product Thumbnail Image

Knee osteoarthritis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator